• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/29/22 11:43:25 AM ET
    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ABOS alert in real time by email

     

    On Tuesday, 81 stocks hit new 52-week lows.

    Noteworthy Points From Today's 52-Week Lows:

    • Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a new 52-week low.
    • The company with the smallest market cap to set a new 52-week low was Statera BioPharma (NASDAQ:STAB).
    • NeoGenomics (NASDAQ:NEO) made the largest move down on the session, with shares plummeting 33.99% to reach its 52-week low.
    • Nuveen Municipal Credit (NYSE:NZF) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    These stocks set new 52-week lows on Tuesday:

    • Grupo Aval Acciones (NYSE:AVAL) shares were down 4.88% for the day, having made a 52-week low of $4.87.
    • Nuveen Municipal Credit (NYSE:NZF) stock dropped to a yearly low on Tuesday of $13.72. Shares traded 0.0% (flat).
    • Blackrock Municipal 2030 (NYSE:BTT) stock hit a new 52-week low of $22.69. The stock was down 0.91% on the session.
    • NeoGenomics (NASDAQ:NEO) stock broke to a new 52-week low of $11.00 on Tuesday. Shares of the company traded down 33.99%.
    • Nuveen Municipal High Inc (NYSE:NMZ) stock set a new 52-week low of $12.77 on Tuesday, moving down 0.47%.
    • Blackrock Muniyield (NYSE:MQY) shares fell to $13.12 on Tuesday, setting a new 52-week low with a shift of down 0.6%.
    • Eaton Vance Municipal (AMEX:EIM) shares were up 0.18% for the day, having made a 52-week low of $11.21.
    • Nuveen Dynamic Municipal (NYSE:NDMO) shares reached a new 52-week low of $12.68 on Tuesday morning, moving down 1.93%.
    • Aveanna Healthcare Hldgs (NASDAQ:AVAH) stock broke to a new 52-week low of $3.81 on Tuesday. Shares of the company traded down 26.9%.
    • Nuveen California (NYSE:NKX) stock dropped to a yearly low on Tuesday of $13.13. Shares traded down 0.38%.
    • Invesco Trust (NYSE:VGM) stock hit a yearly low of $11.20. The stock was down 0.62% for the day.
    • Invesco Quality Municipal (NYSE:IQI) stock broke to a new 52-week low of $10.90 on Tuesday. Shares of the company traded up 0.09%.
    • Volta (NYSE:VLTA) shares fell to $3.19 on Tuesday, setting a new 52-week low with a shift of down 0.15%.
    • Blackrock Municipal IT (NYSE:BFK) shares were down 0.06% for the day, having made a 52-week low of $11.94.
    • Blackrock Muniassets Fund (NYSE:MUA) shares moved down 0.88% on Tuesday to hit a new 52-week low of $12.33, drifting down 0.88%.
    • Incannex Healthcare (NASDAQ:IXHL) shares fell to $9.35 on Tuesday, setting a new 52-week low with a shift of down 7.53%.
    • Eaton Vance Municipal IT (NYSE:EVN) shares made a new 52-week low of $11.48 on Tuesday. The stock was down 0.34% for the day.
    • Blackrock Muniholdings (NYSE:MFL) stock drifted down 0.05% on Tuesday morning to hit a new 52-week low of $12.00.
    • BLACKROCK MUNIYIELD (NYSE:MCA) shares set a new yearly low of $12.80 this morning. The stock was down 0.08% on the session.
    • BNY Mellon Strategic (NYSE:LEO) stock hit a yearly low of $7.03. The stock was down 0.42% for the day.
    • Guggenheim Taxable (NYSE:GBAB) stock set a new 52-week low of $18.35 on Tuesday, moving down 0.38%.
    • Putnam Municipal Opps (NYSE:PMO) stock hit $11.38 on Tuesday morning, setting a new 52-week low for a change of down 0.74%.
    • BlackRock MuniHoldings (NYSE:MUJ) stock hit $12.83 on Tuesday morning, setting a new 52-week low for a change of up 0.55%.
    • Putnam Managed Municipal (NYSE:PMM) shares set a new 52-week low of $6.82. The stock traded down 0.73%.
    • PIMCO Municipal Income (NYSE:PMX) shares moved down 0.3% on Tuesday to hit a new 52-week low of $9.97, drifting down 0.3%.
    • Nuveen Enhanced Municipal (NYSE:NEV) stock hit $12.60 on Tuesday morning, setting a new 52-week low for a change of down 0.13%.
    • Blackrock Muniyield NJ (NYSE:MYJ) shares reached a new 52-week low of $13.00 on Tuesday morning, moving up 0.15%.
    • PIMCO Municipal Income (NYSE:PMF) shares hit a yearly low of $11.65. The stock was down 1.18% on the session.
    • Blackrock NY Municipal (NYSE:BNY) shares set a new yearly low of $11.96 this morning. The stock was up 0.25% on the session.
    • Blackrock Munivest Fund (NYSE:MVT) stock hit a yearly low of $12.65. The stock was down 1.09% for the day.
    • Nuveen Ohio Quality (NYSE:NUO) shares made a new 52-week low of $13.62 on Tuesday. The stock was down 0.29% for the day.
    • Blackrock Investment (NYSE:BKN) stock hit $14.04 on Tuesday morning, setting a new 52-week low for a change of up 0.21%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) shares set a new yearly low of $7.35 this morning. The stock was down 0.61% on the session.
    • Nuveen Select Tax Free (NYSE:NXP) stock hit a new 52-week low of $14.12. The stock was down 0.16% on the session.
    • Pioneer Municipal High IT (NYSE:MHI) shares were down 0.44% for the day, having made a 52-week low of $10.18.
    • Pioneer Muni High Inc (NYSE:MAV) shares set a new 52-week low of $9.60. The stock traded down 0.31%.
    • Invesco Trust For Invnt (NYSE:VTN) shares reached a new 52-week low of $11.49 on Tuesday morning, moving up 0.17%.
    • BNY Mellon Municipal Bond (NYSE:DMB) stock drifted down 0.41% on Tuesday morning to hit a new 52-week low of $12.04.
    • Telesat (NASDAQ:TSAT) shares reached a new 52-week low of $16.77 on Tuesday morning, moving down 1.12%.
    • PIMCO CA Muni Income Fund (NYSE:PZC) shares moved 0.0% (flat) on Tuesday to hit a new 52-week low of $8.67, drifting 0.0% (flat).
    • Acumen Pharmaceuticals (NASDAQ:ABOS) shares set a new 52-week low of $4.30. The stock traded down 0.97%.
    • Eaton Vance New York (AMEX:ENX) shares fell to $10.22 on Tuesday, setting a new 52-week low with a shift of down 0.63%.
    • Vaccitech (NASDAQ:VACC) shares made a new 52-week low of $4.47 on Tuesday. The stock was down 1.53% for the day.
    • Quanergy Systems (NYSE:QNGY) shares made a new 52-week low of $1.90 on Tuesday. The stock was down 1.96% for the day.
    • Mfs High Inc Municipal (NYSE:CXE) shares set a new 52-week low of $4.25. The stock traded down 0.93%.
    • MFS Government Markets (NYSE:MGF) shares set a new 52-week low of $3.71. The stock traded down 0.13%.
    • Annexon (NASDAQ:ANNX) stock drifted up 1.16% on Tuesday morning to hit a new 52-week low of $2.94.
    • RiverNorth Opportunistic (NYSE:RMI) shares moved up 0.87% on Tuesday to hit a new 52-week low of $18.16, drifting up 0.87%.
    • DWS Strategic Municipal (NYSE:KSM) shares hit a yearly low of $10.00. The stock was down 0.2% on the session.
    • Mfs High Yield Municipal (NYSE:CMU) shares hit a yearly low of $3.75. The stock was down 0.53% on the session.
    • Galectin Therapeutics (NASDAQ:GALT) shares reached a new 52-week low of $1.65 on Tuesday morning, moving up 3.61%.
    • Eaton Vance CA Muni (AMEX:CEV) shares made a new 52-week low of $11.26 on Tuesday. The stock was down 0.35% for the day.
    • Neuberger Berman CA Muni (AMEX:NBW) shares moved down 0.25% on Tuesday to hit a new 52-week low of $11.91, drifting down 0.25%.
    • Nuveen Multi-Market (NYSE:JMM) shares were down 0.15% for the day, having made a 52-week low of $6.39.
    • Applied Genetic (NASDAQ:AGTC) stock hit a new 52-week low of $1.13. The stock was 0.0% (flat) on the session.
    • LiqTech International (NASDAQ:LIQT) stock broke to a new 52-week low of $2.33 on Tuesday. Shares of the company traded up 0.8%.
    • Pennsylvania REIT (NYSE:PEI) stock hit a yearly low of $0.61. The stock was down 3.89% for the day.
    • Good Times Restaurants (NASDAQ:GTIM) stock hit a yearly low of $3.49. The stock was up 2.42% for the day.
    • Blackrock Enhanced Gov (NYSE:EGF) stock achieved a new 52-week low on Tuesday morning, hitting $10.89 and moving down 0.18%.
    • Minim (NASDAQ:MINM) stock set a new 52-week low of $0.77 on Tuesday, moving 0.0% (flat).
    • Borqs Technologies (NASDAQ:BRQS) shares hit a yearly low of $0.20. The stock was 0.0% (flat) on the session.
    • PolarityTE (NASDAQ:PTE) stock hit a new 52-week low of $0.26. The stock was down 4.85% on the session.
    • NeuroOne Medical Tech (NASDAQ:NMTC) shares set a new yearly low of $1.08 this morning. The stock was down 3.39% on the session.
    • Soleno Therapeutics (NASDAQ:SLNO) stock hit $0.20 on Tuesday morning, setting a new 52-week low for a change of down 22.29%.
    • Vallon Pharmaceuticals (NASDAQ:VLON) shares set a new 52-week low of $1.74. The stock traded down 3.72%.
    • Statera BioPharma (NASDAQ:STAB) stock hit a yearly low of $0.30. The stock was down 0.45% for the day.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ABOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABOS
    $AGTC
    $ANNX
    $AVAH

    CompanyDatePrice TargetRatingAnalyst
    Aveanna Healthcare Holdings Inc.
    $AVAH
    3/20/2026$13.00Outperform → Strong Buy
    Raymond James
    Annexon Inc.
    $ANNX
    12/23/2025$16.00Buy
    Chardan Capital Markets
    Aveanna Healthcare Holdings Inc.
    $AVAH
    12/8/2025Outperform
    William Blair
    Soleno Therapeutics Inc.
    $SLNO
    11/18/2025$75.00Outperform
    Wolfe Research
    Aveanna Healthcare Holdings Inc.
    $AVAH
    11/13/2025$11.00Outperform
    BMO Capital Markets
    Soleno Therapeutics Inc.
    $SLNO
    10/7/2025$125.00Buy
    Goldman
    Aveanna Healthcare Holdings Inc.
    $AVAH
    9/18/2025$10.00Underweight → Neutral
    Analyst
    Soleno Therapeutics Inc.
    $SLNO
    8/20/2025$123.00Overweight
    Wells Fargo
    More analyst ratings

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aveanna upgraded by Raymond James with a new price target

    Raymond James upgraded Aveanna from Outperform to Strong Buy and set a new price target of $13.00

    3/20/26 10:18:34 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Chardan Capital Markets initiated coverage on Annexon with a new price target

    Chardan Capital Markets initiated coverage of Annexon with a rating of Buy and set a new price target of $16.00

    12/23/25 8:41:58 AM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Aveanna

    William Blair initiated coverage of Aveanna with a rating of Outperform

    12/8/25 8:33:04 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vice President Siffermann William A bought $1,048 worth of shares (100 units at $10.48), increasing direct ownership by 12% to 914 units (SEC Form 4)

    4 - NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND (0001266585) (Issuer)

    3/6/26 5:45:25 PM ET
    $NMZ
    Finance/Investors Services
    Finance

    Chief Business Officer Wambeke David J. bought $670,400 worth of shares (1,000,000 units at $0.67) (SEC Form 4)

    4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)

    3/3/26 8:49:19 AM ET
    $NMTC
    Medical/Dental Instruments
    Health Care

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    SEC Filings

    View All

    SEC Form 424B3 filed by Nuveen Municipal High Income Opportunity Fund

    424B3 - NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND (0001266585) (Filer)

    4/24/26 1:34:40 PM ET
    $NMZ
    Finance/Investors Services
    Finance

    SEC Form DEFA14A filed by Acumen Pharmaceuticals Inc.

    DEFA14A - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)

    4/23/26 4:31:13 PM ET
    $ABOS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Acumen Pharmaceuticals Inc.

    DEF 14A - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)

    4/23/26 4:30:33 PM ET
    $ABOS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration

    EHR-enabled access has the potential to streamline ordering, accelerate clinical decisions, and drive scalable precision oncology adoption NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that its oncology testing portfolio is now available through Epic Aura, enabling seamless access to oncologists and health systems across the United States through the Epic electronic health record (EHR) workflow. Through this integration, physicians can order NeoGenomics' comprehensive suite of tests, spanning solid tumors and hematologic malignancies, and view results in the same system they use to manage patient care.

    4/23/26 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care

    Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call

    ATLANTA, April 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 14, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13759633. The replay will be available until May 21, 2026. Intere

    4/23/26 6:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution

    BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) today announced a distribution of $0.0500 per share of common stock, payable on June 1, 2026 to shareholders of record at the close of business on May 18, 2026. The ex-dividend date is May 18, 2026. The previous distribution announced April 2, 2026 was $0.0420 per share of common stock. The increase to the Fund's distribution is primarily due to higher yields earned on the Fund's investments. The Fund intends to make regular monthly distributions to its common shareholders at a level rate based on its projected performance. At times, to maintain a stable level of distributions, the Fund may pay out less than all of its net inv

    4/22/26 3:51:00 PM ET
    $BK
    $DMB
    Major Banks
    Finance
    Trusts Except Educational Religious and Charitable

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Wowk Robert

    3 - LIQTECH INTERNATIONAL INC (0001307579) (Issuer)

    4/15/26 9:51:47 AM ET
    $LIQT
    Industrial Machinery/Components
    Technology

    SEC Form 4 filed by Carson William H.

    4 - Annexon, Inc. (0001528115) (Issuer)

    4/14/26 4:16:40 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Mills Jason Richard

    4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)

    4/7/26 1:46:50 PM ET
    $NMTC
    Medical/Dental Instruments
    Health Care

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Leadership Updates

    Live Leadership Updates

    View All

    Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update

    NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2025. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, said "We are at an important juncture for the belapectin development program. During 2025, we made meaningful progress advancing the belapectin program and continuing our analysis of the NAVIGATE dataset in patients with MASH cirrhosis and portal hypertension. We are encouraged by the signals observed, including additional biomarkers from the NAVIGATE d

    3/31/26 8:00:00 AM ET
    $GALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.

    NORCROSS, Ga., March 17, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced it has appointed Henry Brem, M.D., as an independent director to its Board of Directors. Dr. Brem is an internationally recognized neurosurgeon-scientist and leader in translational medicine. He serves as the Henry Brem Professor of Neurosurgery at Johns Hopkins University and previously served as Director of the Department of Neurosurgery and Neurosurgeon-in-Chief at The Johns Hopkins Medical Institutions. He is also Co-Director of the Brain Cancer Program at the Sidn

    3/17/26 8:00:00 AM ET
    $GALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer

    REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the appointment of Jennifer Fulk as Chief Financial Officer, succeeding James Mackaness, who announced that he will be retiring from the Company by the end of the first quarter. Mr. Mackaness will serve as a consultant to Soleno through the end of the year to ensure a smooth transition. Mrs. Fulk brings to Soleno more than two decades of public company experience in leading financial strategy, investor relations, financial reporting, and operational efficiency, with a diverse c

    2/26/26 8:00:00 AM ET
    $SLNO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Advantage Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME ADVANTAGE FUND, INC. (0001258943) (Subject)

    12/13/24 4:29:08 PM ET
    $MAV
    Finance Companies
    Finance

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME FUND, INC. (0001223026) (Subject)

    12/13/24 4:29:09 PM ET
    $MHI
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by BNY Mellon Municipal Bond Infrastructure Fund Inc.

    SC 13D/A - BNY Mellon Municipal Bond Infrastructure Fund, Inc. (0001565381) (Subject)

    12/13/24 4:29:03 PM ET
    $DMB
    Trusts Except Educational Religious and Charitable
    Finance

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Financials

    Live finance-specific insights

    View All

    Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call

    ATLANTA, April 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 14, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13759633. The replay will be available until May 21, 2026. Intere

    4/23/26 6:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution

    BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) today announced a distribution of $0.0500 per share of common stock, payable on June 1, 2026 to shareholders of record at the close of business on May 18, 2026. The ex-dividend date is May 18, 2026. The previous distribution announced April 2, 2026 was $0.0420 per share of common stock. The increase to the Fund's distribution is primarily due to higher yields earned on the Fund's investments. The Fund intends to make regular monthly distributions to its common shareholders at a level rate based on its projected performance. At times, to maintain a stable level of distributions, the Fund may pay out less than all of its net inv

    4/22/26 3:51:00 PM ET
    $BK
    $DMB
    Major Banks
    Finance
    Trusts Except Educational Religious and Charitable

    Telesat schedules first quarter 2026 earnings conference call for May 5, 2026

    OTTAWA, Ontario, April 21, 2026 (GLOBE NEWSWIRE) -- Telesat (Nasdaq and TSX:TSAT), one of the world's largest and most innovative satellite operators, has scheduled a conference call on Tuesday, May 5, 2026, at 10:30 a.m. EDT to discuss its financial results for the three month period ended March 31, 2026 Prior to the commencement of the call, Telesat will post a news release containing its financial results on its website (www.telesat.com) under the tab "Investors" and the heading "Investor News." Dial-in Instructions: The toll-free dial-in number for the teleconference is +1-800-715-9871. Callers outside of North America should dial +1-646-307-1963. The access code is 6669954 followed

    4/21/26 7:30:00 AM ET
    $TSAT
    Metal Fabrications
    Industrials

    $ABOS
    $AGTC
    $ANNX
    $AVAH
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Galectin Therapeutics Inc. on Jun 20

    Recently, on June 20, 2024, Galectin Therapeutics Inc. saw an insider purchase by Director Freeman Kevin D. He bought $5,950 worth of shares, which amounted to 2,500 units at a price of $2.38 per share. This transaction increased his direct ownership by 10% to 28,469 units, as reported in the SEC Form 4. It's essential to analyze this insider purchase in the context of previous transactions within the company. On February 7, 2024, Uihlein Richard E was granted 23,256 shares, increasing his direct ownership by 0.23% to 10,268,751 units. Similarly, on the same date, Zordani Richard A. Jr. filed an SEC Form 4. Continuing the trend, a new insider, Carson Benjamin Sr, filed an SEC Form 3 on Febr

    6/20/24 6:44:03 PM ET
    $GALT
    Biotechnology: Pharmaceutical Preparations
    Health Care